Congress: 116 · Status: active · Israel/Palestine classification: pro-Israel
Data (JSON) — machine-readable record of this bill (identifiers, sponsor, classification, actions, and the member-by-member vote breakdown).
Official record on Congress.gov — full text, actions, and cosponsor history for S 3722.
Sponsor: Cruz, Ted (R-Texas)
Expanding Medical Partnerships with Israel to Lessen Dependence on China Act or the EMPIL-DOC Act This bill authorizes a bilateral grant program with Israel to develop health technologies, with an emphasis on the use of technology, personalized medicine, and data in relation to COVID-19 (i.e., coronavirus disease 2019). Technologies to be developed through this program include, among others, artificial intelligence, respiratory assist devices, and diagnostic tests. In addition, the program conditions funding on a matching contribution from the government of Israel.
This bill creates a jointly-funded research program between the US and Israel to develop health technologies, particularly for COVID-19 treatment and diagnosis. Technologies include artificial intelligence tools, breathing devices, and diagnostic tests. Israel must match US funding dollar-for-dollar to participate.
This establishes a new medical research partnership with Israel and directs federal health resources toward joint development. The bill frames the partnership partly as reducing US reliance on Chinese medical technology, which could signal broader strategic alignment on supply chain policy.